Eran C. Gwillim, MD (@egmd__) 's Twitter Profile
Eran C. Gwillim, MD

@egmd__

ID: 1338676733252423682

calendar_today15-12-2020 02:47:35

22 Tweet

17 Followers

168 Following

E.C.Gwillim (@ecgwillim) 's Twitter Profile Photo

'At the finish, you must reconcile yourself to failure. It's not perfect. You have to make your peace with that. How? Well, you sit at your board, you lay out your tools, and you start again.' - Leonard (The Outfit) moviequotesandmore.com/the-outfit-mov… via MovieQuotesandMore

Eran C. Gwillim, MD (@egmd__) 's Twitter Profile Photo

When the torch is passed, it will be held with a steadfast grip! Congratulations to those elected, we eagerly await your term. Lawrence Green, MD #aad2024election #aad2025

Eran C. Gwillim, MD (@egmd__) 's Twitter Profile Photo

Multiple choice diagnosis? Resembles the current testing environment, i.e. multiple-choice test. Would this lead to a better correlation between test scores and clinical diagnostic ability?

Eran C. Gwillim, MD (@egmd__) 's Twitter Profile Photo

The degree of innovation creates the angle to put one in the right place, at the right time, with the right idea (product, service, method, etc.). #Right #Angle #Innovation Google Apple Microsoft IBM Salesforce

Eran C. Gwillim, MD (@egmd__) 's Twitter Profile Photo

A well-designed comparative study between artificial intelligence (AI) and no intelligence (NI) could finally answer the question, is AI better than NI?

Eran C. Gwillim, MD (@egmd__) 's Twitter Profile Photo

I am very excited about the release of this manuscript. A review of clinical trials investigating GPP and Spesolimab, a first-in-class humanized monoclonal antibody that binds to the IL-36 receptor, and antagonizes IL-36 signaling. Boehringer Ingelheim frontiersin.org/journals/immun…

Eran C. Gwillim, MD (@egmd__) 's Twitter Profile Photo

GPP and Spesolimab - an audio summary! <iframe src="widgets.figshare.com/articles/26347…" width="568" height="351" allowfullscreen frameborder="0"></iframe>